Skip to main content
AMRX
NASDAQ Life Sciences

Amneal Ramps Up Progesterone Production Amid Surging US Menopause Treatment Demand

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$16.25
Mkt Cap
$5.184B
52W Low
$7.665
52W High
$16.61
52W Position info
112% above low
Off High info
2.2% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

AMRX has more than doubled off its 52-week low of $7.665.

Summary

US progesterone supplies are tightening due to a sharp increase in demand for menopause treatment, following a late 2025 FDA label change. Amneal Pharmaceuticals, a key manufacturer, is actively increasing its manufacturing capacity at its New York facility to meet this surging demand. This market shift presents a significant opportunity for Amneal to expand its revenue and market share in a growing therapeutic area. CVS Health, among other pharmacies, is also experiencing supply challenges from manufacturers.

At the time of this announcement, AMRX was trading at $16.25 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.2B. The 52-week trading range was $7.67 to $16.61. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

AMRX - Latest Insights

AMRX
Nov 03, 2026, 6:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $20.23
Real-time Price: $19.40 info
Change: -$0.826 (-4%) info
Market Cap: $6.774B info
AMRX
Nov 03, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $20.20
Real-time Price: $19.40 info
Change: -$0.800 (-4%) info
Market Cap: $6.774B info
AMRX
Oct 23, 2026, 4:05 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $20.38
Real-time Price: $19.40 info
Change: -$0.980 (-5%) info
Market Cap: $6.774B info
AMRX
Sep 18, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $18.71
Real-time Price: $19.40 info
Change: +$0.690 (+4%) info
Market Cap: $6.774B info
AMRX
Aug 12, 2026, 6:05 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $17.33
Real-time Price: $19.40 info
Change: +$2.07 (+12%) info
Market Cap: $6.774B info